Therefore, this paper hypothesized that the expression and activation of c-Abl are abnormally elevated in various neurodegenerative diseases (AD, PD, ALS, MS, POCD, etc.), mainly as a result of abnormality in the Tau and Aβ proteins caused by neuroinflammation and oxidative stress (OS). This evidence concerns the gene MAPT and Alzheimer disease.